University Of Birmingham

🇸🇪Sweden

Country: 🇸🇪Sweden

Ownership: Private

Established: 1900-05-01

Employees: 5K

Market Cap: -

Website: http://www.general.bham.ac.uk

Clinical Trials

Can we Save the Rectum by Watchful Waiting or TransAnal Surgery Following (Chemo)Radiotherapy Versus Total Mesorectal Excision for Early REctal Cancer?

Phase 2

Recruiting

Conditions: Adenocarcinoma of the Rectum

Interventions: Procedure: Standard TME surgery
Drug: Long course concurrent chemoradiation with capecitabine and radiotherapy
Radiation: Short course radiotherapy

First Posted Date: 2016-10-26

Last Posted Date: 2024-02-26

Lead Sponsor: University of Birmingham

Target Recruit Count: 380

Registration Number: NCT02945566

Locations: 🇧🇪
University Hospital UZ Leuven, Leuven, Belgium
🇩🇰
Odense University Hospital, Odense, Denmark
🇬🇧
University of Birmingham, Birmingham, United Kingdom

and more 2 locations

Patient Reported Experience Measures Following Hip Fracture Surgery in the Elderly

Conditions: Elderly
Hip Fractures
Emergency Surgery

First Posted Date: 2016-07-25

Last Posted Date: 2016-07-25

Lead Sponsor: University of Birmingham

Target Recruit Count: 15

Registration Number: NCT02842996

An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Phase 2

Completed

Conditions: Diffuse Large B-Cell Lymphoma

Interventions: Drug: AZD 2014
Drug: Rituximab

First Posted Date: 2016-04-26

Last Posted Date: 2020-11-05

Lead Sponsor: University of Birmingham

Target Recruit Count: 36

Registration Number: NCT02752204

Locations: 🇬🇧
Aberdeen Royal Infirmary, Aberdeen, United Kingdom
🇬🇧
University College London Hospitals, London, United Kingdom
🇬🇧
Guys Hospital, London, United Kingdom

and more 6 locations

Viability Testing and Transplantation of Marginal Livers

Not Applicable

Completed

Conditions: Liver Transplantation

Interventions: Device: OrganOx metra

First Posted Date: 2016-04-15

Last Posted Date: 2022-03-11

Lead Sponsor: University of Birmingham

Target Recruit Count: 22

Registration Number: NCT02740608

Locations: 🇬🇧
UHBFT - Queen Elizabeth Hospital, Birmingham, Birmingham, United Kingdom

Pembrolizumab in Patients With Non-Small Cell Lung Cancer and a Performance Status 2

Phase 2

Active, not recruiting

Conditions: Carcinoma, Non-Small-Cell Lung

Interventions: Drug: pembrolizumab

First Posted Date: 2016-04-11

Last Posted Date: 2023-11-29

Lead Sponsor: University of Birmingham

Target Recruit Count: 62

Registration Number: NCT02733159

Locations: 🇬🇧
Maidstone and Tunbridge Wells NHS Trust, Maidstone, Kent, United Kingdom
🇬🇧
Southampton University Hospitals NHS Trust, Southampton, Hampshire, United Kingdom
🇬🇧
The Royal Marsden Hospital, London, United Kingdom

and more 7 locations

International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia

Phase 3

Recruiting

Conditions: Acute Myeloid Leukaemia

Interventions: Drug: Mitoxantrone
Drug: Liposomal daunorubicin
Drug: Gemtuzumab ozogamicin
Drug: Fludarabine
Drug: Cytarabine
Drug: Busulfan
Drug: Cyclophosphamide

First Posted Date: 2016-03-31

Last Posted Date: 2021-10-08

Lead Sponsor: University of Birmingham

Target Recruit Count: 700

Registration Number: NCT02724163

Locations: 🇦🇺
Monash Children's Hospital, Melbourne, Australia
🇦🇺
Women and Children's Hospital Adelaide, Adelaide, Australia
🇦🇺
Queensland Children's Hospital, Brisbane, Australia

and more 65 locations

Spironolactone in Atrial Fibrillation

Phase 4

Conditions: Atrial Fibrillation

Interventions: Drug: Placebo
Drug: Spironolactone

First Posted Date: 2016-02-04

Last Posted Date: 2018-10-11

Lead Sponsor: University of Birmingham

Target Recruit Count: 250

Registration Number: NCT02673463

Locations: 🇬🇧
University of Birmingham Institute of Cardiovascular Sciences, Birmingham, West Midlands, United Kingdom

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

Phase 2

Active, not recruiting

Conditions: Adenocarcinoma
Non-Small Cell Lung Cancer
Carcinoma, Squamous Cell

Interventions: Drug: Vistusertib
Drug: Sitravatinib
Drug: AZD4547
Drug: Palbociclib
Drug: Crizotinib
Drug: AZD5363
Drug: Selumetinib
Drug: Osimertinib
Drug: Durvalumab
Drug: AZD6738
Drug: Docetaxel

First Posted Date: 2016-01-27

Last Posted Date: 2024-05-13

Lead Sponsor: University of Birmingham

Target Recruit Count: 423

Registration Number: NCT02664935

Locations: 🇬🇧
Royal Devon and Exeter Hospital, Exeter, United Kingdom
🇬🇧
University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom
🇬🇧
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

and more 22 locations

Influence of Sedentary Time on Skeletal Muscle Protein Metabolism

Not Applicable

Completed

Conditions: Sedentary Lifestyle

Interventions: Behavioral: 7 days of habitual physical activity followed by 7 days of reduced physical activity

First Posted Date: 2015-12-08

Last Posted Date: 2018-10-11

Lead Sponsor: University of Birmingham

Target Recruit Count: 8

Registration Number: NCT02624011

Locations: 🇬🇧
School of Sport Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom

Enhanced Broccoli Consumption After a Liking Norm and Vegetable Variety Message: Effects After a 24 Hour Delay.

Not Applicable

Completed

Conditions: Eating Behaviour

Interventions: Behavioral: Food-based Control Condition
Behavioral: Liking Social Norm
Behavioral: Descriptive Social Norm
Behavioral: Neutral Control Condition
Behavioral: Health Condition

First Posted Date: 2015-12-01

Last Posted Date: 2015-12-01

Lead Sponsor: University of Birmingham

Target Recruit Count: 400

Registration Number: NCT02618174

Locations: 🇬🇧
University of Birmingham, Birmingham, West Midlands, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy